Mycotopia Therapies, Inc. Quarterly Debt-to-equity in % from Q1 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Mycotopia Therapies, Inc. quarterly Debt-to-equity history and growth rate from Q1 2020 to Q2 2024.
  • Mycotopia Therapies, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -172 %, a 24.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -172 -33.4 -24.1% Jun 30, 2024
Q1 2024 -166 +7.46 +4.31% Mar 31, 2024
Q4 2023 -151 +181 +54.6% Dec 31, 2023
Q3 2023 -127 +988 +88.6% Sep 30, 2023
Q2 2023 -138 -1.57K -110% Jun 30, 2023
Q1 2023 -173 -1.39K -114% Mar 31, 2023
Q4 2022 -332 -2.42K -116% Dec 31, 2022
Q3 2022 -1.11K -3.75K -142% Sep 30, 2022
Q2 2022 1.43K +1.93K Jun 30, 2022
Q1 2022 1.22K +1.75K Mar 31, 2022
Q4 2021 2.09K +2.63K Dec 31, 2021
Q3 2021 2.64K +8.32K Sep 30, 2021
Q2 2021 -499 -680 -376% Jun 30, 2021
Q1 2021 -530 -723 Mar 31, 2021
Q4 2020 -543 Dec 31, 2020
Q3 2020 -5.68K* Sep 30, 2020
Q2 2020 181 Jun 30, 2020
Q1 2020 193* Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.